08-20 ISpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks NE
08-14 ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
08-07 ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants MT
08-07 ISpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants AQ
08-07 E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen AQ
08-06 ISpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants AQ
05-18 ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-12 E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement AQ
05-10 ISpecimen Inc. announced that it has received $2.500004 million in funding CI
05-08 ISpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement AQ
05-07 ISpecimen Inc. announced that it expects to receive $2.499999 million in funding CI
04-27 ISpecimen Announces 1-for-40 Reverse Stock Split AQ
04-24 ISpecimen Announces 1-for-40 Reverse Stock Split NE
04-20 MicroCap Movers: ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, MMCP in the News AQ
04-13 Ispecimen Inc - annual meeting repeatedly adjourned for lack of quorum - SEC filing RE
04-09 ISpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time NE
04-01 ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-31 ISpecimen Inc. Auditor Raises 'Going Concern' Doubt CI
03-16 ISpecimen Achieves Rapid Procurement Milestone for Influenza Research NE
03-12 ISpecimen Launches AI Agent Revolutionizing Biospecimen Matching NE
03-12 ISpecimen Inc. Launches AI-Powered Inventory Agent CI
02-23 Ispecimen Inc. Announces Resignation of Independent Director Siyun Yang, Effective February 17, 2026 CI
02-06 ISpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete NE
02-06 ISpecimen Achieves Rapid Procurement Milestone for Influenza Research NE
12-30 ISpecimen Inc. announced that it has received $5.5 million in funding CI
No results match your criteria